The Q4 earnings report for Viridian Therapeutics (NASDAQ:VRDN) was released on Thursday, February 26, 2026 at 07:01 AM.
Here’s what investors need to know about the latest announcement.
Earnings
Viridian Therapeutics missed estimated earnings by -12.5%, reporting an EPS of $-1.08 versus an estimate of $-0.96.
Revenue was up $60 thousand from the same period last year.
Overview of Past Earnings
Last quarter the company beat on EPS by $0.55 which was followed by a 12.61% increase in the share price the next day.
Here’s a look at Viridian Therapeutics’s past performance:
To track all earnings releases for Viridian Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
